产品标题 产品货号 产品规格 厂家
Human Soft tissue; Leiomyosarcoma, metastatic from ORIGENE TECHNOLOGIESCS6398465x5umORIGENE TECHNOLOGIES
Human Soft tissue; Leiomyosarcoma, recurrent from ORIGENE TECHNOLOGIESCS8063135x5umORIGENE TECHNOLOGIES
Human Soft tissue; Leiomyosarcoma, recurrent from ORIGENE TECHNOLOGIESCS8081865x5umORIGENE TECHNOLOGIES
Human Soft tissue; Leiomyosarcoma, recurrent from ORIGENE TECHNOLOGIESCS8090125x5umORIGENE TECHNOLOGIES
Human Soft tissue; Leiomyosarcoma, recurrent from ORIGENE TECHNOLOGIESCS6322775x5umORIGENE TECHNOLOGIES
Human Soft tissue; Lipoma, atypical from ORIGENE TECHNOLOGIESCS7121325x5umORIGENE TECHNOLOGIES
Human Soft tissue; Liposarcoma from ORIGENE TECHNOLOGIESCS7059455x5umORIGENE TECHNOLOGIES
Human Soft tissue; Liposarcoma from ORIGENE TECHNOLOGIESCS7059465x5umORIGENE TECHNOLOGIES
Human Soft tissue; Liposarcoma from ORIGENE TECHNOLOGIESCS7081185x5umORIGENE TECHNOLOGIES
Human Soft tissue; Liposarcoma from ORIGENE TECHNOLOGIESCS7132735x5umORIGENE TECHNOLOGIES
Human Soft tissue; Liposarcoma from ORIGENE TECHNOLOGIESCS8009635x5umORIGENE TECHNOLOGIES
Human Soft tissue; Liposarcoma from ORIGENE TECHNOLOGIESCS8009645x5umORIGENE TECHNOLOGIES
Human RNA: Ovary: left; Adenocarcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIESCR5619305 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: left; Adenocarcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIESCR5619875 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: left; Adenocarcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIESCR5621965 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: left; Adenocarcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIESCR5625185 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: left; Adenocarcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIESCR5630445 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: left; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCR5612985 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: left-Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCR566315n/aORIGENE TECHNOLOGIES
Human RNA: Ovary: left; Adenocarcinoma of ovary, serous from ORIGENE TECHNOLOGIESCR5601315 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: left; Adenocarcinoma of ovary, serous from ORIGENE TECHNOLOGIESCR5602315 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: left; Adenocarcinoma of ovary, serous from ORIGENE TECHNOLOGIESCR5605345 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: left; Adenocarcinoma of ovary, serous from ORIGENE TECHNOLOGIESCR5611555 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: left; Adenocarcinoma of ovary, serous from ORIGENE TECHNOLOGIESCR5613515 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: left; Adenocarcinoma of ovary, serous from ORIGENE TECHNOLOGIESCR5621825 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: left; Adenocarcinoma of ovary, serous from ORIGENE TECHNOLOGIESCR5624975 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: left-Adenocarcinoma of ovary, serous from ORIGENE TECHNOLOGIESCR566320n/aORIGENE TECHNOLOGIES
Human RNA: Ovary: left-Adenocarcinoma of ovary, serous from ORIGENE TECHNOLOGIESCR566343n/aORIGENE TECHNOLOGIES
Human RNA: Ovary: left; Adenocarcinoma of ovary, serous, metastatic from ORIGENE TECHNOLOGIESCR5593495 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: left; Adenocarcinoma of ovary, serous, metastatic from ORIGENE TECHNOLOGIESCR5594055 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: left; Adenocarcinoma of ovary, serous, metastatic from ORIGENE TECHNOLOGIESCR5624675 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: left; Adenocarcinoma of ovary, serous, metastatic from ORIGENE TECHNOLOGIESCR5628765 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: left; Adenocarcinoma of ovary, serous, metastatic from ORIGENE TECHNOLOGIESCR5628895 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: left; Brenner tumor from ORIGENE TECHNOLOGIESCR5598045 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: left; Carcinoma of ovary from ORIGENE TECHNOLOGIESCR5614585 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: left; Carcinoma of ovary from ORIGENE TECHNOLOGIESCR5621455 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: left; Carcinoma of ovary, clear cell from ORIGENE TECHNOLOGIESCR5603645 ugORIGENE TECHNOLOGIES
Spindlin family, member 2B (SPIN2B), transcript variant 1 from ORIGENE TECHNOLOGIESLY423547100 ugORIGENE TECHNOLOGIES
Spindlin family, member 2B (SPIN2B), transcript variant 3 from ORIGENE TECHNOLOGIESLY423549100 ugORIGENE TECHNOLOGIES
Spindlin family, member 2B (SPIN2B), transcript variant 3 from ORIGENE TECHNOLOGIESLY425189100 ugORIGENE TECHNOLOGIES
Spindlin family, member 4 (SPIN4) from ORIGENE TECHNOLOGIESLY422845100 ugORIGENE TECHNOLOGIES
Spindlin family, member 3 (SPIN3), transcript variant 1 from ORIGENE TECHNOLOGIESLY423191100 ugORIGENE TECHNOLOGIES
Spindlin 1 (SPIN1) from ORIGENE TECHNOLOGIESLY416457100 ugORIGENE TECHNOLOGIES
SPINK6 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4045121 kitORIGENE TECHNOLOGIES
SPINK2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4053881 kitORIGENE TECHNOLOGIES
SPINK1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4065741 kitORIGENE TECHNOLOGIES
SPINK13 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4134231 kitORIGENE TECHNOLOGIES
SPINK4 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4148181 kitORIGENE TECHNOLOGIES
SPINK7 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4188671 kitORIGENE TECHNOLOGIES
SPINK14 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4200671 kitORIGENE TECHNOLOGIES
 |< < 2215 2216 2217 2218 2219 2220 2221 2222 2223 > >| 第 2219/6274 页